Welcome to our dedicated page for Nasdaq news (Ticker: NDAQ), a resource for investors and traders seeking the latest updates and insights on Nasdaq stock.
The Nasdaq, Inc. (Nasdaq: NDAQ) news page on Stock Titan aggregates official announcements, market updates, and regulatory disclosures from a global technology company that operates The Nasdaq Stock Market and related capital markets businesses. Nasdaq’s communications highlight its role in serving corporate clients, investment managers, banks, brokers, and exchange operators through data, analytics, software, exchange capabilities, and index solutions.
Visitors can review news on listings and index changes, such as annual reconstitutions of the Nasdaq-100 Index and constituent updates involving companies being added or removed. Nasdaq also issues releases about capital formation activity, including the amount of capital raised from new listings and notable exchange transfers, as well as updates from Nasdaq Global Indexes on methodology and index families across asset classes and geographies.
The feed also features corporate finance and balance sheet actions, including announcements about cash tender offers for outstanding senior notes, early tender results, and pricing details. In addition, Nasdaq publishes information about investor events, such as scheduled quarterly and full-year earnings announcements, investor conference calls, and the availability of volume statistics and presentation materials.
Because Nasdaq operates The Nasdaq Stock Market, its news includes market operations and regulatory notices like trading halts, delisting decisions, and references to listing and delisting rules. Technology and data partnerships, such as the integration of Nasdaq eVestment into third-party platforms, also appear in the company’s releases. This page helps readers follow how Nasdaq’s exchange, index, data, and technology activities evolve over time through its own public disclosures.
On January 10, 2022, Nasdaq (NDAQ) announced its December 2021 monthly and quarterly trading volumes, estimated revenue capture, and listing statistics for the quarter ending December 31, 2021. These details are available on Nasdaq's investor relations website. The company emphasizes its technology offerings and services that support capital markets. Nasdaq also provides caution regarding forward-looking statements, highlighting various risks, including economic fluctuations and potential impacts from the COVID-19 pandemic.
Nasdaq (NDAQ) has announced that it will release its Fourth Quarter 2021 financial results on January 26, 2022. The results will be available for review at 8:00 AM Eastern Time, preceded by a press release posted on the Nasdaq Investor Relations website at approximately 7:00 AM Eastern. Senior management, including the CEO and CFO, will discuss the results during a conference call, which will be accessible via webcast. Investors can also access an audio replay of the conference call later on the website.
Summary not available.
In 2021, Nasdaq (NDAQ) led the U.S. exchanges with 743 IPOs, raising $180 billion, achieving a 76% win rate among operating companies. Notably, 63% of all IPO proceeds in the U.S. were raised through Nasdaq. The exchange featured the largest IPO, the highest number of SPAC business combinations, and welcomed 35 companies, including Honeywell, transferring a total market value of $360.4 billion to Nasdaq. The year also marked the launch of Nasdaq Private Market as an independent entity, aimed at enhancing trading in private stocks.
Equinix (Nasdaq: EQIX) has announced a multi-year partnership with Nasdaq (Nasdaq: NDAQ) to enhance the NY11 data center in Carteret, New Jersey. This collaboration aims to develop Nasdaq's cloud infrastructure, providing low-latency edge compute capabilities. Nasdaq has utilized Equinix for over 13 years, benefiting from its interconnected platform and extensive ecosystem. The agreement will further support Nasdaq's hybrid infrastructure, enabling access to critical cloud services and facilitating future deployments across North America, Europe, and Asia-Pacific.
Nasdaq announced the annual reconstitution results of the Nasdaq Biotechnology Index, effective December 20, 2021. The updated Index will include 129 new biotechnology and pharmaceutical securities, enhancing its coverage and tracking ability. Notable additions include Brooklyn ImmunoTherapeutics and Lexicon Pharmaceuticals. Meanwhile, 21 companies, such as MediciNova and Assembly Biosciences, will be removed from the Index. This reconstitution reflects Nasdaq's commitment to maintaining a robust and relevant biotechnology sector representation.
Nasdaq (NDAQ) has announced the annual reconstitution of the Nasdaq-100 Index, effective before market open on December 20, 2021. Six companies will be added: Airbnb, Fortinet, Palo Alto Networks, Lucid Group, Zscaler, and Datadog. Concurrently, CDW Corporation, Fox Corporation, Cerner, Check Point, Trip.com Group, and Incyte will be removed from the Index. This reconstitution occurs each December, aligning with the quarterly quadruple witch expiration. The Nasdaq-100 Index serves as a benchmark for various financial products, including the Invesco QQQ Trust.
Summary not available.
Summary not available.
On December 2, 2021, Nasdaq (NDAQ) reported its monthly trading volumes for November 2021, with detailed statistics available on its investor relations website. This data includes monthly trading volumes and quarterly capture rates, which are critical for assessing market activity and performance. Nasdaq, as a global technology company, provides essential data, analytics, software, and services to optimize business operations across capital markets. Investors can access in-depth financial information on Nasdaq's performance through their official channels.